BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30550937)

  • 1. Levels of circulating soluble LR11, a regulator of smooth muscle cell migration, are highly associated with atherosclerotic plaques in patients with carotid artery stenosis.
    Harada M; Jiang M; Terai K; Ebinuma H; Hiruta N; Schneider WJ; Sugo N; Nagao T; Bujo H
    Clin Chim Acta; 2019 Mar; 490():69-76. PubMed ID: 30550937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble form of LR11, a regulator of smooth muscle cell migration, is a novel marker for intima-media thickness of carotid arteries in type 2 diabetes.
    Jin W; Jiang M; Han X; Han X; Murano T; Hiruta N; Ebinuma H; Piao L; Schneider WJ; Bujo H
    Clin Chim Acta; 2016 Jun; 457():137-41. PubMed ID: 27095609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced circulating soluble LR11 in patients with coronary organic stenosis.
    Takahashi M; Bujo H; Jiang M; Noike H; Saito Y; Shirai K
    Atherosclerosis; 2010 Jun; 210(2):581-4. PubMed ID: 20047743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of circulating soluble LR11 on long-term clinical outcomes in patients with coronary artery disease.
    Ogita M; Miyauchi K; Kasai T; Tsuboi S; Wada H; Naito R; Konishi H; Dohi T; Tamura H; Okazaki S; Yanagisawa N; Shimada K; Suwa S; Jiang M; Bujo H; Daida H
    Atherosclerosis; 2016 Jan; 244():216-21. PubMed ID: 26687467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ang II-stimulated migration of vascular smooth muscle cells is dependent on LR11 in mice.
    Jiang M; Bujo H; Ohwaki K; Unoki H; Yamazaki H; Kanaki T; Shibasaki M; Azuma K; Harigaya K; Schneider WJ; Saito Y
    J Clin Invest; 2008 Aug; 118(8):2733-46. PubMed ID: 18618022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LR11/SorLA links triglyceride-rich lipoproteins to risk of developing cardiovascular disease in FH patients.
    Vongpromek R; Bujo H; Hoekstra M; Schneider WJ; van der Zee L; Schinkel AF; Korporaal SJ; Dik WA; Ebinuma H; Jiang M; Verhoeven AJ; Sijbrands EJ; Mulder MT
    Atherosclerosis; 2015 Dec; 243(2):429-37. PubMed ID: 26520897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating soluble LR11, a novel marker of smooth muscle cell proliferation, is enhanced after coronary stenting in response to vascular injury.
    Ogita M; Miyauchi K; Jiang M; Kasai T; Tsuboi S; Naito R; Konishi H; Dohi T; Yokoyama T; Okazaki S; Shimada K; Bujo H; Daida H
    Atherosclerosis; 2014 Nov; 237(1):374-8. PubMed ID: 25443876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-CSF induces the release of the soluble form of LR11, a regulator of myeloid cell mobilization in bone marrow.
    Shimizu N; Nakaseko C; Jiang M; Nishii K; Yokote K; Iseki T; Higashi M; Tamaru J; Schneider WJ; Bujo H
    Ann Hematol; 2014 Jul; 93(7):1111-22. PubMed ID: 24577511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an immunoassay for the quantification of soluble LR11, a circulating marker of atherosclerosis.
    Matsuo M; Ebinuma H; Fukamachi I; Jiang M; Bujo H; Saito Y
    Clin Chem; 2009 Oct; 55(10):1801-8. PubMed ID: 19661140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of measuring soluble LR11, a circulating marker of atherosclerosis and HbA1c in familial hypercholesterolemia.
    Nohara A; Kobayashi J; Kawashiri MA; Tada H; Inazu A; Jiang M; Mabuchi H; Bujo H
    Clin Biochem; 2014 Sep; 47(13-14):1326-8. PubMed ID: 24859021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased circulating soluble LR11 in patients with acute coronary syndrome.
    Ogita M; Miyauchi K; Dohi T; Tsuboi S; Miyazaki T; Yokoyama T; Yokoyama K; Shimada K; Kurata T; Jiang M; Bujo H; Daida H
    Clin Chim Acta; 2013 Jan; 415():191-4. PubMed ID: 23127357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease.
    Watanabe K; Suzuki H; Jiang M; Haniu H; Numano F; Hoshina S; Saitoh A; Uchiyama M; Bujo H
    Atherosclerosis; 2016 Mar; 246():94-7. PubMed ID: 26761773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomarkers for Atherosclerotic Diseases: Significance of Intimal Smooth Muscle Cell-Derived Circulating Marker].
    Bujo H
    Rinsho Byori; 2016 Jun; 64(6):651-656. PubMed ID: 30695319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Novel biomarker for pathological immature cells--soluble form of LR11].
    Bujo H
    Rinsho Byori; 2012 May; 60(5):469-76. PubMed ID: 22774576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating soluble LR11, a differentiation regulator for vascular cells, is increased during pregnancy and exaggerated in patients with pre-eclampsia.
    Ishida H; Jiang M; Ebinuma H; Hiruta N; Schneider WJ; Kinoshita T; Bujo H
    Clin Chim Acta; 2019 Oct; 497():172-177. PubMed ID: 31299181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble LR11/SorLA levels are highly increased and ameliorated by chemotherapy in acute leukemias.
    Sakai S; Nakaseko C; Takeuchi M; Ohwada C; Shimizu N; Tsukamoto S; Kawaguchi T; Jiang M; Sato Y; Ebinuma H; Yokote K; Iwama A; Fukamachi I; Schneider WJ; Saito Y; Bujo H
    Clin Chim Acta; 2012 Oct; 413(19-20):1542-8. PubMed ID: 22750733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of serum soluble LR11 in newly diagnosed diffuse large B-cell lymphoma: A multicenter prospective analysis.
    Sugita Y; Ohwada C; Kawaguchi T; Muto T; Tsukamoto S; Takeda Y; Mimura N; Takeuchi M; Sakaida E; Shimizu N; Tanaka H; Abe D; Fukazawa M; Sugawara T; Aotsuka N; Nishiwaki K; Shono K; Ebinuma H; Fujimura K; Bujo H; Yokote K; Nakaseko C
    Clin Chim Acta; 2016 Dec; 463():47-52. PubMed ID: 27725222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating LR11 is a novel soluble-receptor marker for early-stage clinical conditions in patients with non-Hodgkin's lymphoma.
    Fujimura K; Ebinuma H; Fukamachi I; Ohwada C; Kawaguchi T; Shimizu N; Takeuchi M; Sakaida E; Jiang M; Nakaseko C; Bujo H
    Clin Chim Acta; 2014 Mar; 430():48-54. PubMed ID: 24394293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble LR11 associates with aortic root calcification in asymptomatic treated male patients with familial hypercholesterolemia.
    Vongpromek R; Bos S; Ten Kate GR; Bujo H; Jiang M; Nieman K; Schneider W; Roeters van Lennep JE; Verhoeven AJM; Sijbrands EJG; Mulder MT
    Atherosclerosis; 2017 Oct; 265():299-304. PubMed ID: 28637586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.